IL146841A0 - Tanacetum parthenium extract - Google Patents

Tanacetum parthenium extract

Info

Publication number
IL146841A0
IL146841A0 IL14684100A IL14684100A IL146841A0 IL 146841 A0 IL146841 A0 IL 146841A0 IL 14684100 A IL14684100 A IL 14684100A IL 14684100 A IL14684100 A IL 14684100A IL 146841 A0 IL146841 A0 IL 146841A0
Authority
IL
Israel
Prior art keywords
tanacetum parthenium
parthenium extract
extracts
reduced
extract
Prior art date
Application number
IL14684100A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11383110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL146841(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of IL146841A0 publication Critical patent/IL146841A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adornments (AREA)
  • Massaging Devices (AREA)
  • Cosmetics (AREA)
  • Air Bags (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14684100A 1999-06-03 2000-05-31 Tanacetum parthenium extract IL146841A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001244A IT1312342B1 (it) 1999-06-03 1999-06-03 Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
PCT/EP2000/004976 WO2000074695A2 (en) 1999-06-03 2000-05-31 Tanacetum parthenium extract

Publications (1)

Publication Number Publication Date
IL146841A0 true IL146841A0 (en) 2002-07-25

Family

ID=11383110

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14684100A IL146841A0 (en) 1999-06-03 2000-05-31 Tanacetum parthenium extract
IL146841A IL146841A (en) 1999-06-03 2001-11-29 Extract of parthenium tenacetum and pharmaceutical preparations containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146841A IL146841A (en) 1999-06-03 2001-11-29 Extract of parthenium tenacetum and pharmaceutical preparations containing it

Country Status (22)

Country Link
US (2) US6224875B1 (ja)
EP (1) EP1181030B1 (ja)
JP (1) JP4712258B2 (ja)
KR (1) KR100727121B1 (ja)
CN (1) CN1265814C (ja)
AT (1) ATE249232T1 (ja)
AU (1) AU769365B2 (ja)
CA (1) CA2375910C (ja)
CZ (1) CZ301703B6 (ja)
DE (1) DE60005174T2 (ja)
DK (1) DK1181030T3 (ja)
ES (1) ES2206251T3 (ja)
HK (1) HK1046245B (ja)
HU (1) HU228799B1 (ja)
IL (2) IL146841A0 (ja)
IT (1) IT1312342B1 (ja)
NO (1) NO328245B1 (ja)
PL (1) PL197514B1 (ja)
PT (1) PT1181030E (ja)
RU (1) RU2241475C2 (ja)
SK (1) SK285014B6 (ja)
WO (1) WO2000074695A2 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
MXPA03008391A (es) * 2001-03-16 2004-11-12 Johnson & Johnson Composicion que contiene extracto de matricaria y uso de la misma.
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
CN1882354B (zh) * 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
AU2013201510B2 (en) * 2006-02-21 2015-07-16 Isp Investments Inc. Parthenolide Free Bioactive Ingredients from Feverfew (Tanacetum Parthenium) and Processes for their Production
AU2007217003B2 (en) * 2006-02-21 2013-04-04 Isp Investments Inc. Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
CN102781406B (zh) 2010-03-01 2015-07-08 强生消费者公司 具有理想的整体颜色的护肤组合物
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
FR2695931B1 (fr) * 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
KR100755798B1 (ko) * 1999-06-03 2007-09-07 죤슨 앤 죤슨 컨슈머 프랑스 에스에이에스 화란국화(타나세텀 파르테니움) 추출물을 포함하는 국소 조성물과, 이 조성물을 사용해서 염증 질환을 치료 및 예방하는 방법

Also Published As

Publication number Publication date
ITMI991244A0 (it) 1999-06-03
DK1181030T3 (da) 2004-01-26
HUP0201258A2 (en) 2002-08-28
ITMI991244A1 (it) 2000-12-03
KR100727121B1 (ko) 2007-06-12
CN1353612A (zh) 2002-06-12
NO20015867D0 (no) 2001-11-30
NO328245B1 (no) 2010-01-18
DE60005174T2 (de) 2004-07-15
NO20015867L (no) 2001-11-30
RU2241475C2 (ru) 2004-12-10
PT1181030E (pt) 2003-12-31
JP2003501392A (ja) 2003-01-14
CZ301703B6 (cs) 2010-06-02
US6224875B1 (en) 2001-05-01
SK285014B6 (sk) 2006-04-06
IT1312342B1 (it) 2002-04-15
US6479080B2 (en) 2002-11-12
KR20020019452A (ko) 2002-03-12
PL197514B1 (pl) 2008-04-30
HUP0201258A3 (en) 2007-10-29
HU228799B1 (en) 2013-05-28
HK1046245A1 (en) 2003-01-03
DE60005174D1 (de) 2003-10-16
PL352107A1 (en) 2003-07-28
SK17482001A3 (sk) 2002-04-04
AU5527200A (en) 2000-12-28
US20010021400A1 (en) 2001-09-13
ATE249232T1 (de) 2003-09-15
AU769365B2 (en) 2004-01-22
EP1181030B1 (en) 2003-09-10
JP4712258B2 (ja) 2011-06-29
CZ20014304A3 (cs) 2002-03-13
CA2375910A1 (en) 2000-12-14
WO2000074695A2 (en) 2000-12-14
ES2206251T3 (es) 2004-05-16
WO2000074695A3 (en) 2001-05-03
CN1265814C (zh) 2006-07-26
EP1181030A2 (en) 2002-02-27
IL146841A (en) 2006-12-31
CA2375910C (en) 2011-11-01
HK1046245B (zh) 2007-02-23

Similar Documents

Publication Publication Date Title
HK1046245A1 (en) Tanacetum parthenium extract
AU6205600A (en) Hydrophobic, high tg cycloaliphatic epoxy resins
EP1016679A3 (en) Polytetrafluoroethylene resins
WO2002094002A3 (en) Cultivated agarwood
MXPA01007928A (es) Composiciones de recubrimiento de curado en dos etapas.
GB9906619D0 (en) Compositions
WO2005104722A3 (en) Crude extracts from andrographis paniculata
ZA99322B (en) Adhesives and resins, and processes for their production.
WO1995000594A3 (en) Photodegradation-resistant electrodepositable primer compositions
AU5029500A (en) Multiple-dose, flush-through injector
AU2002353082A1 (en) Epoxidized acetals and thioacetals, episulfidized acetals and thioacetals, and reworkable thermosetting resin compositions formulated therefrom
EP1275665A4 (en) ACTINICALLY RADIATION-CURABLE RESINS, PROCESS FOR THEIR PREPARATION AND COMPOSITION OF THERMOSETTING RESINS
AU2003302165A8 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
WO1997045454A3 (en) Terpolymerization
AU2002248642A1 (en) Low tg ethylene-based polymer, cycloolefin polymer blends
AU3307100A (en) Crosslinkable coating compositions
AU7404798A (en) Self-dispersing curable epoxy resins, dispersions made therewith, and coat ing compositions made therefrom
CA2314716A1 (en) Modified polysaccharides exhibiting altered biological recognition
PL354428A1 (en) Water-dilutable etherified melamine-formeldehyde resins
WO2000046419A3 (de) Metallisierbares formteil
AU7655500A (en) Alkyldipropylenentriamines and their adducts as hardeners for expoxy resins
AU2741097A (en) Decorative, high-pressure laminates made with thermosetting melamine resins modified with sorbitol
MXPA03008758A (es) Preparacion de resinas funcionales de epoxi.
WO1999053091A3 (de) Gdnf-kodierende dna, teile davon und gdnf-varianten
AU2001264035A1 (en) Flexible, insulating and heat-stable composite materials

Legal Events

Date Code Title Description
FF Patent granted